Logo image of 1FRE.MI

FRESENIUS SE & CO KGAA (1FRE.MI) Stock Price, Quote, News and Overview

BIT:1FRE - Euronext Milan - DE0005785604 - Common Stock - Currency: EUR

40.89  -2.8 (-6.41%)

1FRE.MI Quote, Performance and Key Statistics

FRESENIUS SE & CO KGAA

BIT:1FRE (7/18/2025, 7:00:00 PM)

40.89

-2.8 (-6.41%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services
Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap23.03B
Shares563.24M
Float411.39M
Yearly Dividend0
Dividend Yield2.37%
PE12.7
Fwd PE11.03
Earnings (Next)08-06 2025-08-06
IPO12-18 1986-12-18


1FRE.MI short term performance overview.The bars show the price performance of 1FRE.MI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30 40 50

1FRE.MI long term performance overview.The bars show the price performance of 1FRE.MI in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of 1FRE.MI is 40.89 EUR.

FRESENIUS SE & CO KGAA / 1FRE Daily stock chart

1FRE.MI Competitors/Peers

The largest stocks on the EU markets in the "Health Care Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
CVS.DE CVS HEALTH CORP 9.6 66.31B
FME.DE FRESENIUS MEDICAL CARE AG 13.93 26.56B
FRE.DE FRESENIUS SE & CO KGAA 13.14 23.83B
V3V.DE FAMICORD AG 36.07 89.08M

About 1FRE.MI

Company Profile

1FRE logo image Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. The company is headquartered in Bad Homburg, Hessen. The firm has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.

Company Info

FRESENIUS SE & CO KGAA

Else-Kroener-Str. 1

BAD HOMBURG HESSEN DE

Employees: 177091

1FRE Company Website

1FRE Investor Relations

Phone: 4961726080

FRESENIUS SE & CO KGAA / 1FRE.MI FAQ

What is the stock price of FRESENIUS SE & CO KGAA today?

The current stock price of 1FRE.MI is 40.89 EUR. The price decreased by -6.41% in the last trading session.


What is the ticker symbol for FRESENIUS SE & CO KGAA stock?

The exchange symbol of FRESENIUS SE & CO KGAA is 1FRE and it is listed on the Euronext Milan exchange.


On which exchange is 1FRE.MI stock listed?

1FRE.MI stock is listed on the Euronext Milan exchange.


What is the price forecast or stock price prediction for FRESENIUS SE & CO KGAA stock?

23 analysts have analysed 1FRE.MI and the average price target is 49.8 EUR. This implies a price increase of 21.8% is expected in the next year compared to the current price of 40.89. Check the FRESENIUS SE & CO KGAA stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is FRESENIUS SE & CO KGAA worth?

FRESENIUS SE & CO KGAA (1FRE.MI) has a market capitalization of 23.03B EUR. This makes 1FRE.MI a Large Cap stock.


How many employees does FRESENIUS SE & CO KGAA have?

FRESENIUS SE & CO KGAA (1FRE.MI) currently has 177091 employees.


Is FRESENIUS SE & CO KGAA (1FRE.MI) expected to grow?

The Revenue of FRESENIUS SE & CO KGAA (1FRE.MI) is expected to grow by 4.95% in the next year. Check the estimates tab for more information on the 1FRE.MI EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy FRESENIUS SE & CO KGAA (1FRE.MI) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does FRESENIUS SE & CO KGAA (1FRE.MI) stock pay dividends?

FRESENIUS SE & CO KGAA (1FRE.MI) has a dividend yield of 2.37%. The yearly dividend amount is currently 0. Check the full fundamental report for a detailed analysis of 1FRE.MI dividend history, reliability and sustainability.


When does FRESENIUS SE & CO KGAA (1FRE.MI) report earnings?

FRESENIUS SE & CO KGAA (1FRE.MI) will report earnings on 2025-08-06.


What is the Price/Earnings (PE) ratio of FRESENIUS SE & CO KGAA (1FRE.MI)?

The PE ratio for FRESENIUS SE & CO KGAA (1FRE.MI) is 12.7. This is based on the reported non-GAAP earnings per share of 3.22 and the current share price of 40.89 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 1FRE.MI.


1FRE.MI Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to 1FRE.MI.


Chartmill TA Rating
Chartmill Setup Rating

1FRE.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to 1FRE.MI. Both the profitability and the financial health of 1FRE.MI get a neutral evaluation. Nothing too spectacular is happening here.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

1FRE.MI Financial Highlights

Over the last trailing twelve months 1FRE.MI reported a non-GAAP Earnings per Share(EPS) of 3.22. The EPS increased by 785.11% compared to the year before.


Industry RankSector Rank
PM (TTM) 1.91%
ROA 0.98%
ROE 2.17%
Debt/Equity 0.62
Chartmill High Growth Momentum
EPS Q2Q%31.34%
Sales Q2Q%-0.93%
EPS 1Y (TTM)785.11%
Revenue 1Y (TTM)-20.12%

1FRE.MI Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to 1FRE.MI. The Buy consensus is the average rating of analysts ratings from 23 analysts.

For the next year, analysts expect an EPS growth of 10.09% and a revenue growth 4.95% for 1FRE.MI


Ownership
Inst Owners36.44%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts83.48
Price Target49.8 (21.79%)
EPS Next Y10.09%
Revenue Next Year4.95%